Pharmaceutical Glass Ampoules Market size was valued at USD 3.92 billion in 2023 and is expected to cross USD 9.56 billion by the end of 2036, registering more than 7.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pharmaceutical glass ampoules is estimated at USD 4.14 billion.
The growth of the market can be attributed to the rapid growth of pharmaceutical industry around the globe, stringent government regulations to improve the quality of manufactured drugs, and the rising preference for injection based treatments, such as that of diabetes. Apart from these, the emergence of glass as a cost-effective, safe and efficient packaging solution is also expected to drive market growth in the near future. Furthermore, growing demand for COVID-19 vaccination across the world is evaluated to offer ample opportunities to the pharmaceutical glass ampoules market in 2021 and the following years. For instance, till date India has witnessed the largest demand for COVID-19 vaccines in the world. The country has secured more than 2 billion vaccine doses in total.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
7.1% |
|
Base Year Market Size (2023) |
USD 3.92 billion |
|
Forecast Year Market Size (2036) |
USD 9.56 billion |
|
Regional Scope |
|
The pharmaceutical glass ampoules market is segmented by type into open funnel, closed funnel, straight stem, and others, out of which, the straight stem segment is anticipated to hold the largest share in the market on account of deployment of advanced technologies among drug packaging manufacturers and growing emphasis on improving product quality. In addition, on the basis of drug type, the segment for generic drugs is projected to grab the largest market share owing to the increasing geriatric population, growing number of incidences of chronic diseases and escalating expiration of drug patents. Moreover, the biologic segment is assessed to grow with the highest growth rate over the forecast period on the ability of biologics to effectively treat several types of autoimmune diseases and cancer, and rising usage of glass packaging for these drugs.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Capacity |
|
|
By Drug Type |
|
On the basis of geographical analysis, the pharmaceutical glass ampoules market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The market in the North America industry is estimated to account for largest revenue share by 2036, led by increasing demand for glass ampoules and the rising spending of the pharmaceutical industry in the region. Additionally, Europe is expected to be the second largest shareholder in the market in the coming years, which can be credited to the growing R&D activities in the medical sector and presence of strong market players in the region. However, the pharmaceutical glass ampoules market in Asia Pacific is evaluated to grow with the highest CAGR during the forecast period ascribing to the increasing health consciousness amongst people, growing disposable income, and rise in the prevalence of chronic disorders in the region. In India, more than 2 million people suffered from cancer in 2018. Out of these, approximately 785,000 people succumbed to the disease in that year.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?